Myopia and Presbyopia Treatment Market Poised for 8 % Growth, Set to Hit $31.43 Billion by 2029

What market dynamics are playing a key role in accelerating the growth of the myopia and presbyopia treatment market?
The anticipated increase in the elderly population is predicted to boost the myopia and presbyopia treatment market's expansion. The elderly population is composed of individuals who are aged 65 and over. Due to diminished immunity and age, this population group is more susceptible to various diseases. The risk of developing myopia, presbyopia, and other eye-related ailments increases with age in the elderly population. Treatments for myopia and presbyopia involve the examination of the eyes' visual and microscopic components. These findings assist in the identification and management of a multitude of eye-related conditions within the elderly population. For example, a World Health Organization (WHO) report published in October 2022 revealed that by 2030, one in every six people around the world is projected to be 60 or older. By 2050, the global population of people aged 60 and over will reach 2.1 billion. Those aged 80 years and above will add 426 million to their current population between 2020 and 2050. Therefore, the increasing elderly population is contributing significantly to the growth of the myopia and presbyopia treatment market.

Get Your Myopia and Presbyopia Treatment Market Report Here:
https://www.thebusinessresearchcompany.com/report/myopia-and-presbyopia-treatment-global-market-report

How will the growth rate of the myopia and presbyopia treatment market shape industry trends by 2034?
There has been significant expansion in the market size of myopia and presbyopia treatment in the past few years. The market, which was worth $21.04 billion in 2024, is projected to rise to $22.7 billion in 2025, indicative of a compound annual growth rate (CAGR) of 7.9%. Factors influencing this upward trend during the historic period include the rising incidences of myopia and presbyopia, measures taken to raise awareness and education, lifestyle changes and increase in screen time, a consumer bias towards non-surgical treatments, economic growth coupled with healthcare expenditure, strides in clinical research and development, and better reach of eyecare services.

The market for myopia and presbyopia treatments is likely to witness a robust growth in the years to come. The market value is projected to reach $31.43 billion by 2029, growing at a compound annual growth rate (CAGR) of 8.5%. The growth during the forecast period is linked to the advent of gene therapies for eye disorders, emphasis on improving life quality through vision corrective measures, increasing preference for orthokeratology, cultural influences in eyecare practices, and a shift to preventive eyecare measures. Furthermore, the key trends during the forecast period involve the adoption of telehealth for vision care, pharmacological interventions, tailor-made contact lenses, devices for controlling myopia, state-of-the-art intraocular lenses (IoLS), refractive surgery for presbyopia, and lens implant technologies.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7892&type=smp

What trends are poised to drive the future success of the myopia and presbyopia treatment market?
The myopia and presbyopia treatment market is seeing a rising trend towards the use of advanced technological solutions. A significant approach taken by leading companies in the market is the development and promotion of these innovative technological solutions to maintain their market stature. For example, in September 2024, Entod Pharmaceuticals, an Indian company, introduced PresVu Eye Drops, a product designed specifically to treat presbyopia, a prevalent vision condition often seen in those over 40. PresVu, approved by the Drug Controller General of India (DCGI), targets the reduction of reliance on reading glasses while providing eye lubrication simultaneously. The efficacy and safety of these eye drops for prolonged usage are assured by the cutting-edge dynamic buffer technology used in their formulation.

Which primary segments of the myopia and presbyopia treatment market are driving growth and industry transformations?
The myopia and presbyopia treatment market covered in this report is segmented -

1) By Disease Type: Myopia, Presbyopia
2) By Myopia Treatment Type: Corrective, Surgical, Drugs
3) By Presbyopia Treatment Type: Prescription Lenses, Contact Lenses, Intraocular Lenses, Refractive Surgery

Subsegments:
1) By Myopia: Eyeglasses And Contact Lenses, Refractive Surgery, Pharmacological Treatments, Orthokeratology
2) By Presbyopia: Multifocal Eyeglasses, Bifocal Contact Lenses, Presbyopia-Correcting Surgery, Pharmacological Treatments

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7892

Which geographical regions are pioneering growth in the myopia and presbyopia treatment market?
North America was the largest region in the myopia and presbyopia treatment market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the myopia and presbyopia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the influential players reshaping the myopia and presbyopia treatment market landscape?
Major companies operating in the myopia and presbyopia treatment market are ALCON Inc., Bausch & Lomb Incorporated, Carl Zeiss AG, Essilor Ltd., Hagg Striet UK Ltd., Johnson & Johnson Vision Inc., Nidek Corporation, Topcon Corporation, Zimmer Ophthalmic Systems AG, AbbVie Inc., Orasis Pharmaceuticals Ltd., Regeneron Pharmaceuticals Inc., Sydnexis Inc., The Cooper Companies Inc., Staar Surgical Co., Eyenovia Inc., Allergan PLC, Hoya Corporation, Novartis AG, Menicon Co. Ltd., CooperVision Inc., Visioneering Technologies Inc., AcuFocus Inc., Ocular Therapeutix Inc., SightGlass Vision Inc., Presbia PLC, Ophthotech Corporation, OphthaliX Inc., LensGen Inc., Lightico Ltd., RxSight Inc., Perfect Lens LLC

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=7892&type=smp

What Is Covered In The Myopia and Presbyopia Treatment Global Market Report?

• Market Size Forecast: Examine the myopia and presbyopia treatment market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the myopia and presbyopia treatment market for a structured understanding.
• Key Players Overview: Analyze major players in the myopia and presbyopia treatment market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the myopia and presbyopia treatment market.
• Segment Contributions: Evaluate how different segments drive overall growth in the myopia and presbyopia treatment market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the myopia and presbyopia treatment market.
• Industry Challenges: Identify potential risks and obstacles affecting the myopia and presbyopia treatment market.
• Competitive Landscape: Review strategic developments in the myopia and presbyopia treatment market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.